WO1995018604A1 - Traitement topique de la photophobie oculaire - Google Patents
Traitement topique de la photophobie oculaire Download PDFInfo
- Publication number
- WO1995018604A1 WO1995018604A1 PCT/IB1995/000003 IB9500003W WO9518604A1 WO 1995018604 A1 WO1995018604 A1 WO 1995018604A1 IB 9500003 W IB9500003 W IB 9500003W WO 9518604 A1 WO9518604 A1 WO 9518604A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ocular
- photophobia
- ophthalmically acceptable
- surgery
- group
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
L'invention se rapporte à l'utilisation d'un agent anti-inflammatoire non stéroïdien dans la préparation d'une composition pharmaceutique ophtalmique destinée à prévenir, traiter ou maîtriser la photophobie oculaire.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU12493/95A AU1249395A (en) | 1994-01-11 | 1995-01-03 | Topical treatment of ocular photophobia |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18017894A | 1994-01-11 | 1994-01-11 | |
US08/180,178 | 1994-01-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1995018604A1 true WO1995018604A1 (fr) | 1995-07-13 |
Family
ID=22659506
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB1995/000003 WO1995018604A1 (fr) | 1994-01-11 | 1995-01-03 | Traitement topique de la photophobie oculaire |
Country Status (4)
Country | Link |
---|---|
AU (1) | AU1249395A (fr) |
IL (1) | IL112256A0 (fr) |
WO (1) | WO1995018604A1 (fr) |
ZA (1) | ZA95134B (fr) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999059634A1 (fr) * | 1998-05-15 | 1999-11-25 | Wakamoto Pharmaceutical Co., Ltd. | Gouttes oculaires anti-inflammatoires |
US8920820B2 (en) | 2001-12-12 | 2014-12-30 | Boehringer Ingelheim Vetmedica Gmbh | Highly concentrated stable meloxicam solutions for needleless injection |
US8992980B2 (en) | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
US9101529B2 (en) | 2009-10-12 | 2015-08-11 | Boehringer Ingelheim Vetmedica Gmbh | Containers for compositions comprising meloxicam |
US9149480B2 (en) | 2010-03-03 | 2015-10-06 | Boehringer Ingeleheim Vetmedica GmbH | Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats |
US9795568B2 (en) | 2010-05-05 | 2017-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Low concentration meloxicam tablets |
US9993557B2 (en) | 2000-06-20 | 2018-06-12 | Boehringer Ingelheim Vetmedica Gmbh | Highly concentrated stable meloxicam solutions |
US10548901B2 (en) | 2004-02-23 | 2020-02-04 | Boehringer Ingelheim Vetmedica Gmbh | Meloxicam for the treatment of respiratory diseases in pigs |
US11643429B2 (en) * | 2019-04-18 | 2023-05-09 | Azura Ophthalmics Ltd. | Compounds and methods for the treatment of ocular disorders |
-
1995
- 1995-01-03 AU AU12493/95A patent/AU1249395A/en not_active Abandoned
- 1995-01-03 WO PCT/IB1995/000003 patent/WO1995018604A1/fr active Application Filing
- 1995-01-05 IL IL11225695A patent/IL112256A0/xx unknown
- 1995-01-10 ZA ZA95134A patent/ZA95134B/xx unknown
Non-Patent Citations (8)
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999059634A1 (fr) * | 1998-05-15 | 1999-11-25 | Wakamoto Pharmaceutical Co., Ltd. | Gouttes oculaires anti-inflammatoires |
US9993557B2 (en) | 2000-06-20 | 2018-06-12 | Boehringer Ingelheim Vetmedica Gmbh | Highly concentrated stable meloxicam solutions |
US8920820B2 (en) | 2001-12-12 | 2014-12-30 | Boehringer Ingelheim Vetmedica Gmbh | Highly concentrated stable meloxicam solutions for needleless injection |
US10098891B2 (en) | 2001-12-12 | 2018-10-16 | Boehringer Ingelheim Vetmedica Gmbh | Highly concentrated stable meloxicam solutions for needleless injection |
US9066955B2 (en) | 2002-10-25 | 2015-06-30 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
US8992980B2 (en) | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
US10548901B2 (en) | 2004-02-23 | 2020-02-04 | Boehringer Ingelheim Vetmedica Gmbh | Meloxicam for the treatment of respiratory diseases in pigs |
US9186296B2 (en) | 2009-10-12 | 2015-11-17 | Boehringer Ingelheim Vetmedica Gmbh | Containers for compositions comprising meloxicam |
US9101529B2 (en) | 2009-10-12 | 2015-08-11 | Boehringer Ingelheim Vetmedica Gmbh | Containers for compositions comprising meloxicam |
US9149480B2 (en) | 2010-03-03 | 2015-10-06 | Boehringer Ingeleheim Vetmedica GmbH | Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats |
US9795568B2 (en) | 2010-05-05 | 2017-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Low concentration meloxicam tablets |
US9943486B2 (en) | 2010-05-05 | 2018-04-17 | Boehringer Ingelheim Vetmedica Gmbh | Low concentration meloxicam tablets |
US11643429B2 (en) * | 2019-04-18 | 2023-05-09 | Azura Ophthalmics Ltd. | Compounds and methods for the treatment of ocular disorders |
Also Published As
Publication number | Publication date |
---|---|
IL112256A0 (en) | 1995-03-30 |
AU1249395A (en) | 1995-08-01 |
ZA95134B (en) | 1995-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Colin | The role of NSAIDs in the management of postoperative ophthalmic inflammation | |
US5811446A (en) | Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor | |
US5610184A (en) | Method for sustained and extended corneal analgesia | |
KR100889170B1 (ko) | 안구 건조의 치료에 있어서 리멕솔론의 용도 | |
JP5583310B2 (ja) | 眼球の症状の予防及び治療のための眼科用製剤 | |
US4454151A (en) | Use of pyrrolo pyrroles in treatment of ophthalmic diseases | |
US5360611A (en) | Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation | |
Koay | The emerging roles of topical non-steroidal anti-inflammatory agents in ophthalmology. | |
AU695888B2 (en) | Use of non-steroidal cyclooxygenase inhibitors to treat elevated intraocular pressure | |
AU2011274245B2 (en) | Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease | |
Kenyon | Decision-making in the therapy of external eye disease: noninfected corneal ulcers | |
Nichols et al. | Topical nonsteroidal anti-inflammatory agents in ophthalmology | |
WO1995018604A1 (fr) | Traitement topique de la photophobie oculaire | |
US6531120B2 (en) | Ophthalmic histamine compositions and uses thereof | |
Gallenga et al. | Efficacy of diclofenac eyedrops in preventing postoperative inflammation and long-term cystoid macular edema | |
MXPA06013170A (es) | Metodo para tratar trastornos de queratoconjuntivitis seca y uveitis. | |
Kymionis et al. | Dry eye after photorefractive keratectomy with adjuvant mitomycin C | |
FRASER-SMITH et al. | Effect of ketorolac on Pseudomonas aeruginosa ocular infection in rabbits | |
JPS58174310A (ja) | 抗炎症点眼剤 | |
US6399107B1 (en) | Use of inhibitors of gag synthesis for the treatment of corneal haze | |
KR20000048671A (ko) | 각막 상피하 혼탁 억제제 | |
WO2023098537A1 (fr) | Nouvelle utilisation d'alanyl-glutamine et composition ophtalmique comprenant de l'alanyl-glutamine | |
Hashemian et al. | The effect of topical diclofenac sodium 0.1% on the corneal epithelial healing after photorefractive keratectomy | |
CA2177578C (fr) | Inhibiteurs non steroides pour le traitement de l'elevation de la pression intraoculaire | |
WO2020152527A1 (fr) | Compositions pharmaceutiques ophtalmiques à base de vitamines, d'acides aminés et de minéraux pour le traitement de la cataracte immature |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA FI JP MX NO NZ US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |